ID | Name | Number of studies | |
|---|---|---|---|
| CL_0000788 | naive B cell | 28 | |
| CL_0000785 | mature B cell | 0 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| FCER2 | 19 | 49% ± 16% | 0 | 3 | |
| BLK | 19 | 32% ± 10% | 0 | 5 | |
| VPREB3 | 19 | 47% ± 17% | 0 | 7 | |
| FCRL1 | 18 | 35% ± 12% | 0 | 3 | |
| TNFRSF13C | 17 | 43% ± 13% | 0 | 4 | |
| FCRLA | 17 | 36% ± 14% | 0 | 5 | |
| CD19 | 17 | 45% ± 12% | 0 | 8 | |
| TCL1A | 20 | 64% ± 19% | 1 | 7 | |
| MS4A1 | 20 | 88% ± 8% | 1 | 9 | |
| CD79A | 20 | 90% ± 7% | 1 | 13 | |
| PAX5 | 19 | 30% ± 10% | 1 | 7 | |
| CD72 | 19 | 37% ± 14% | 1 | 8 | |
| FCMR | 20 | 56% ± 16% | 1 | 27 | |
| NIBAN3 | 17 | 47% ± 18% | 1 | 6 | |
| HLA-DOA | 16 | 25% ± 10% | 1 | 9 | |
| BANK1 | 20 | 62% ± 12% | 2 | 9 | |
| CD79B | 20 | 67% ± 15% | 2 | 13 | |
| CD22 | 19 | 43% ± 14% | 2 | 8 | |
| BTK | 19 | 26% ± 9% | 2 | 17 | |
| CYB561A3 | 18 | 36% ± 11% | 2 | 15 | |
| PLEKHF2 | 17 | 26% ± 7% | 2 | 12 | |
| STAP1 | 16 | 23% ± 5% | 2 | 6 | |
| HVCN1 | 20 | 47% ± 14% | 3 | 12 | |
| TMEM154 | 18 | 22% ± 5% | 3 | 12 | |
| NCF1 | 20 | 60% ± 16% | 3 | 36 | |
| CCR7 | 18 | 36% ± 12% | 3 | 17 | |
| SP140 | 19 | 27% ± 8% | 3 | 28 | |
| CD40 | 19 | 36% ± 8% | 4 | 16 | |
| CD83 | 20 | 57% ± 20% | 4 | 29 | |
| ADAM28 | 18 | 40% ± 6% | 4 | 17 |
| GO_0051712 | Biological process | positive regulation of killing of cells of another organism |
| GO_0050851 | Biological process | antigen receptor-mediated signaling pathway |
| GO_0002768 | Biological process | immune response-regulating cell surface receptor signaling pathway |
| GO_1903980 | Biological process | positive regulation of microglial cell activation |
| GO_1903376 | Biological process | regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
| GO_0071467 | Biological process | cellular response to pH |
| GO_0002925 | Biological process | positive regulation of humoral immune response mediated by circulating immunoglobulin |
| GO_0098761 | Biological process | cellular response to interleukin-7 |
| GO_1990959 | Biological process | eosinophil homeostasis |
| GO_0002115 | Biological process | store-operated calcium entry |
| GO_0050861 | Biological process | positive regulation of B cell receptor signaling pathway |
| GO_0038095 | Biological process | Fc-epsilon receptor signaling pathway |
| GO_0032732 | Biological process | positive regulation of interleukin-1 production |
| GO_0002503 | Biological process | peptide antigen assembly with MHC class II protein complex |
| GO_0009268 | Biological process | response to pH |
| GO_0002322 | Biological process | B cell proliferation involved in immune response |
| GO_0045069 | Biological process | regulation of viral genome replication |
| GO_0033590 | Biological process | response to cobalamin |
| GO_1904178 | Biological process | negative regulation of adipose tissue development |
| GO_0030592 | Biological process | DNA ADP-ribosylation |
| GO_0031296 | Biological process | B cell costimulation |
| GO_0048304 | Biological process | positive regulation of isotype switching to IgG isotypes |
| GO_0072540 | Biological process | T-helper 17 cell lineage commitment |
| GO_0050855 | Biological process | regulation of B cell receptor signaling pathway |
| GO_1902227 | Biological process | negative regulation of macrophage colony-stimulating factor signaling pathway |
| GO_1905665 | Biological process | positive regulation of calcium ion import across plasma membrane |
| GO_0060100 | Biological process | positive regulation of phagocytosis, engulfment |
| GO_1904151 | Biological process | positive regulation of microglial cell mediated cytotoxicity |
| GO_0019724 | Biological process | B cell mediated immunity |
| GO_0036010 | Biological process | protein localization to endosome |
| Cell type name | naive B cell |
| Synonyms | naive B lymphocyte naive B-cell naive B-lymphocyte |
| Description | A naive B cell is a mature B cell that has the phenotype surface IgD-positive, surface IgM-positive, CD20-positive, CD27-negative and that has not yet been activated by antigen in the periphery. |
| Parent | CL_0000785 |